VULCAM Pitch Deck (2020): 18-Slide Series A Deck

See all 18 slides of the VULCAM pitch deck — a 2020 deck — with a slide-by-slide teardown of what the deck does well and where it falls short.

VULCAM’s 2020 investor deck targets the $150 billion musculoskeletal injury market with a visual AI platform for motion analysis. The company demonstrates significant early traction, listing high-prestige paying customers including Nike Sport Research Lab, USA Track & Field, and several top-ranked university sports medicine programs. The business model is bifurcated between a high-touch 'PRO' hardware/software subscription for institutions and a scalable mobile app for individual therapists and coaches. While the deck provides a detailed four-year financial forecast projecting a jump from $10…

Key takeaways

VULCAM Pitch Deck Analysis

VULCAM’s investor deck from May 2020 presents a vision for the future of healthcare centered on prevention through AI-powered biomechanics. The deck is structured to move quickly from a massive macroeconomic problem to specific, high-prestige institutional validation. By focusing on the portability and ease of use of their motion analysis software, VULCAM attempts to disrupt a field traditionally dominated by expensive, stationary laboratory equipment.

Slide 1: Title and Vision

The cover slide introduces the brand with the tagline "Discover the Invisible." It sets a broad healthcare context, stating that "Prevention is the future of all healthcare!" and positioning AI as the tool to achieve this for biomechanics. The slide establishes a professional tone and includes a 2020 copyright notice for Vulcan Vision.

Slide 2: The Problem in Sports Biomechanics

VULCAM identifies a significant financial and human cost associated with musculoskeletal injuries. Key data points include:

Annual cost of $150B for musculoskeletal injuries in the USA. · 5 million pediatric injuries, which are noted as "rapidly increasing." · The claim that most non-impact injuries are preventable. · A lack of cost-effective tools that fit into the clinical workflow.

Analysis: This slide successfully frames the problem as both a massive financial burden for the healthcare system and a personal tragedy for athletes (loss of scholarships and early retirement).

Slide 3: Market Potential

Sports biomechanics global market: $6.6B (2019) to $9.1B (2024). · Body monitoring & evaluation: $4.2B (2019). · Musculoskeletal global market: $1B (2019). · VULCAM Potential: 4-10% of the $1B market, equating to $40-100M in revenue or 1-2.5M users.

Additional context is provided regarding North American dominance (40% market share) and the specific value of knee-related injuries ($2.5B annually). They also cite a 22% CAGR for the physical therapy job outlook.

Slide 4: Visual Competition

VULCAM uses a standard 2x2 matrix to position itself against competitors. The axes are "Ease-of-Use" and "Effective Feedback." VULCAM places itself in the top-right quadrant, claiming superiority over:

Analysis: While these charts are subjective, it clearly communicates VULCAM's intended value proposition: a tool that is both simpler to use and more insightful than legacy video analysis software.

Slide 5: Product in Action

Titled "VULCAM Today," this slide shows a split-screen video/image of an athlete (a baseball pitcher) undergoing motion analysis. It emphasizes "Motion Analysis" as the core current capability. The visuals suggest a multi-angle capture system, which aligns with the later mention of a 2-3 device recording setup.

Slide 6: Institutional Testimonials

Social proof is delivered through two high-ranking academic and clinical figures:

Prof. Mark Paterno (Cincinnati Children's): "I believe VULCAM could revolutionize all of physical therapy!" · Prof. Jill McNitt-Gray (USC Biomechanics Research Lab): "...making VULCAM a perfect tool."

These testimonials are strategically chosen to validate the product's utility in both research and clinical recovery (specifically ACL prevention).

Slide 7: Business Model

VULCAM PRO: A hardware and software subscription sold directly to universities, institutions, and professional teams. It is described as a "plug-n-play recording setup." · VULCAM APP: An in-app subscription for a 2-3 device recording app, targeted at individual therapists, coaches, and eventually consumers. · Future Add-on: A subscription for 2D motion tracking is listed as "To be added."

Slide 8: Paying Customers

This is arguably the strongest slide in the deck. It lists eight high-profile paying customers:

USA Track & Field (Chula Vista and Colorado Springs) · University of Miami Health System (Sports Medicine) · USC (Biomechanics & Physical Therapy) · Ohio State (ACL Research) · Cincinnati Children's (CCHMC) · Duke University (ACLR Rehabilitation) · High Point University (Biomechanics) · Nike Sport Research Lab (NSRL)

Analysis: Having Nike and the US Olympic training centers as paying customers in 2020 provides immense credibility that the technology meets elite professional standards.

Slide 9: Financial Summary

The deck concludes the provided sequence with a detailed four-year projection (2020-2023):

Revenue: Grows from $104k (2020) to $3.22M (2023). · Gross Profit: Scales from 75% to 96%. · EBITDA: Projected to turn positive in 2023 at $1.79M. · Headcount: Remains lean, growing from 4 to 9 people. · Metrics: App downloads are projected to hit 250k by 2023, while PRO kit sales grow from 8 to 43 units.

A sidebar note indicates that working capital calculations assume investments of $800k in 2020 and $500k in 2022.

What VULCAM Does Well

The deck excels at institutional validation . For a seed or early-stage health-tech company, listing Nike and Duke University as paying customers is a powerful signal of product-market fit. The clear distinction between the "PRO" institutional model and the scalable "APP" model shows a sophisticated understanding of how to capture both high-value contracts and high-volume users. The financial slide is also unusually detailed for a pitch deck, providing a full P&L view rather than just a revenue bar chart.

What is Missing

The most glaring omission in this 9-slide sample is the Team Slide . In early-stage fundraising, the pedigree of the founders—especially in a technical field like AI biomechanics—is often as important as the traction. We do not know if the founders are data scientists, former athletes, or medical doctors. Additionally, there is no Ask Slide . While the financial summary mentions $800k and $500k investment figures for capital modeling, it does not explicitly state what the company is raising at the time of the deck's publication or what the specific milestones for that funding would be.

Founder Takeaways

Founders should look at Slide 8 as a masterclass in social proof . Instead of just listing logos, VULCAM includes the specific department and the national ranking of the institution (e.g., "US rank #1"). This adds layers of prestige to the customer list. Furthermore, the use of a Financial Summary table (Slide 9) that includes unit economics (kits sold vs. licenses sold) is a great way to show investors that you understand the levers of your own growth. However, always ensure your deck includes a team slide to humanize the data and prove you are the right people to execute the plan.

Frequently asked questions

What specific problem does VULCAM solve in the sports industry?
VULCAM addresses the high cost and complexity of biomechanics analysis. Slide 2 notes that musculoskeletal injuries cost the US $150 billion annually and that most non-impact injuries are preventable. The company aims to provide cost-effective tools that fit into the clinical workflow, moving away from expensive lab setups to portable AI-driven motion analysis.
Who are VULCAM's primary customers according to the deck?
The deck highlights elite institutions as current paying customers. Slide 8 lists Nike Sport Research Lab (NSRL), USA Track & Field, the University of Miami Sports Medicine, USC, Ohio State, Duke University, and Cincinnati Children's Hospital. These represent top-tier athletic and medical organizations, providing strong social proof for the technology's efficacy.
How does VULCAM generate revenue?
VULCAM uses a two-tier subscription model. The 'VULCAM PRO' is a hardware and software bundle sold directly to universities and professional teams. The 'VULCAM APP' is an in-app subscription for therapists and coaches using 2-3 mobile devices for recording. Slide 7 also mentions a future revenue stream from 2D motion tracking subscriptions.
What are the company's financial growth expectations?
Slide 9 projects significant scaling. Revenue is expected to grow from $104,000 in 2020 to over $3.2 million by 2023. During this period, the company expects to reach EBITDA positivity in 2023 ($1.79M) while maintaining a lean team, growing from 4 to 9 employees.
What is missing from this pitch deck?
The provided slides lack a dedicated team slide, which is critical for assessing the founders' technical and clinical expertise. Additionally, while slide 9 mentions investment amounts for working capital calculations ($800k and $500k), there is no explicit 'Ask' slide detailing the current round's terms, valuation, or specific use of funds.
Cover slide of the VULCAM pitch deck — 2020
VULCAM pitch deck, slide 1 (2020)

VULCAM pitch deck: the facts

Company
VULCAM
Year
2020
Stage
Early Stage (Seed/Series A)
Slides
18
Sector
Sports Technology / Health Tech
Deck type
Investor Deck

VULCAM pitch deck PDF

The full VULCAM deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the VULCAM pitch deck was used for

This is VULCAM’s investor deck dated May 2020, presented as an early-stage (Seed/Series A) raise for its AI-driven biomechanics and multi-angle video technology in sports medicine and performance analysis. The company’s product, marketed as VULCAM, enables synchronized multi-angle video capture using iOS devices, already deployed in professional sports and sports medicine environments. The deck positions a progression from professional hardware–software bundles toward a scalable consumer app, aiming to leverage traction with elite institutional customers such as Nike and USA Track & Field as stated in the deck description. The fundraising goal at the time, as described in ecosystem articles, was to support U.S. market expansion, hiring sales and marketing personnel, and raising the company’s first round in the U.S.

Business model: VULCAM is a video technology product used for biomechanics and movement analysis in sports performance, sports medicine and physical therapy education, delivered as multi-angle, time-synchronized video capture using networked iOS devices.

Headquarters: The company operates with an office in Philadelphia and is characterized as a Finnish startup, indicating operations in both Finland and the United States.

Industry: Sports Technology / Health Tech, focused on sports medicine, physical therapy and sports coaching use cases.

Use of funds as presented: A 2019 Science Center article states that VULCAM’s milestones for its U.S. expansion include hiring sales and marketing personnel and raising its first funding round in the U.S. to ramp up growth, indicating that proceeds from the contemplated raise were intended to support U.S. market expansion and commercial scaling.

What happened after the VULCAM deck

Publicly available information documents VULCAM’s evolution from a Finnish startup to an early-stage company with an office in Philadelphia, a scalable multi-angle video technology product launched in 2019, and deployment in professional sports and sports medicine environments including U.S. Olympic training sites. No specific, externally verified details on the outcome, size or investors of the M

What the VULCAM deck got right

What could have been stronger

How an investor would read this deck

What draws attention

Risks that stand out

Questions this deck invites

What founders can take from the VULCAM deck

VULCAM pitch deck: common questions

What does VULCAM do?

VULCAM is a sports and health technology product that enables multi-angle, time-synchronized video capture using multiple iOS devices for biomechanics and movement analysis in sports performance, sports medicine and physical therapy education.

Where is VULCAM based?

According to a 2019 article by the Science Center, VULCAM is an early-stage tech company from Finland that moved to Philadelphia and joined the U.S. Market Expansion Fellowship to scale its business and raise its first round in the United States. Health Incubator Helsinki also describes VULCAM as a Finnish startup with an office in Philadelphia and a main market focus on North America.

Who are VULCAM’s target customers and users?

Ecosystem profiles and incubator articles indicate that VULCAM’s primary customers and target markets are in sports medicine, physical therapy and sports coaching, particularly in North America. The existing deck description further claims institutional customers like Nike and USA Track & Field, although these specific customers are not independently confirmed in other sources.

Has VULCAM raised funding and from whom?

Public profiles and incubator writeups emphasize VULCAM’s participation in Health Incubator Helsinki and the Science Center’s U.S. Market Expansion Fellowship, its scalable product launch in 2019, and deployment of VULCAM PRO kits in professional environments including United States Olympic training sites. However, no specific funding round amounts or named institutional investors are verified in the available sources.

What was the purpose of VULCAM’s May 2020 investor deck?

The May 2020 investor deck presents VULCAM’s AI-driven sports biomechanics solution and its roadmap from professional hardware–software bundles to a broader consumer app, as well as its traction with professional sports and sports medicine customers. It was used around the time the company was seeking its first U.S. funding round to support U.S. market expansion and sales and marketing hiring.

Sources

Funding and outcome facts on this page were researched on 2026-08-22 from the pages below.

Related fundraising guides (24)

Decks from the same year (1)

Browse companies alphabetically (1)

More pitch deck teardowns (16)

Recently published pitch deck teardowns (12)

Fundraising library · Pitch deck examples · Investor directory · Founder database